CME GROUP INC
CMENASDAQ🏆 #136 by market capUS Equity
$777.49▼ $37.55 (−4.83%)
Simulated price1h—
24h▼ 4.8%
7d▲ 193.6%
14d▲ 192.8%
30d▲ 217.3%
1y▲ 181.8%
🏦Market Cap
$94.80B
Mid Cap
📈Revenue Growth (YoY)
+16.6%
Healthy
📊Gross Margin
96.0%
High
💵FCF Margin
33.4%
Strong
⚖️P/S Ratio
7.6x
Fair
Otter Score
50
Weak
Trading Snapshot
- Day Range
- $768.97 – $785.59
- 52-Week Range
- $218.31 – $329.16
- Volume
- $6.10B
- Avg Volume
- $6.92B
- Shares Outstanding
- 359.6M
- Next Earnings
- Sep 2, 2026
Fundamentals Snapshot
- Annual Revenue
- $12.48B
- Last Q Revenue
- $3.44B
- P/E Ratio
- 22.3
- P/S Ratio
- 7.6x
- EPS (TTM)
- $11.86
- Dividend Yield
- 4.26%
Why Investors Own CME
- ✓High-growth profile — revenue up +23.3% YoY with expanding US Equity exposure.
- ✓Healthy economics — 78% gross margin and 10% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$12.48B▲ +19.0% YoY
Gross Margin (TTM)
77.8%▲ +1.8% YoY
Operating Income (TTM)
$4.38B▲ +19.0% YoY
Free Cash Flow (TTM)
$1.27B▲ +19.0% YoY
About CME GROUP INC
A company profile for CME GROUP INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
50/100
Analyst Price Target
ⓘAverage Target
$809.83
▲ +4.2% Upside
High Target$998.66
Low Target$656.51
Based on 23 analysts
Latest News & Updates
🚀
MarketWatch·2h ago
CME GROUP INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
MarketWatch·5h ago
Analysts lift CME price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
MarketWatch·1d ago
CME GROUP INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.